A major limitation to the widespread use of hematopoietic stem cells (HSC) is the relatively crude level of our knowledge of how to maintain these cells in vitro without loss of the long-term multilineage growth and differentiation properties required for their clinical utility. An experimental and theoretical framework for predicting and controlling the outcome of HSC stimulation by exogenous cytokines would thus be useful. An emerging theme from recent HSC expansion studies is that a net gain in HSC numbers requires the maintenance of critical signaling ligand(s) above a threshold level. These ligand-receptor complex thresholds can be maintained, for example, by high concentrations of soluble cytokines or by extracellular matrix- or cell-bound cytokine presentation. According to such a model, when the relevant ligand-receptor interaction falls below a critical level, the probability of a differentiation response is increased; otherwise, self-renewal is favored. Thus, in addition to the identity of a particular receptor-ligand interaction being important to the regulation of stem cell responses, the quantitative nature of this interaction, as well as the dynamics of receptor expression, internalization, and signaling, may have a significant influence on stem cell fate decisions. This review uses examples from hematopoiesis and other tissue systems to examine existing evidence for a role of receptor activation thresholds in regulating hematopoietic stem cell self-renewal versus differentiation events.

Transplantation of hematopoietic stem cells (HSC) has an established and unique position in the treatment of human disease. This promising approach is limited, however, by a lack of knowledge about how to maintain these cells in vitro without loss of the very long-term multilineage growth and differentiation properties required for their clinical utility. A theoretical framework for predicting and controlling the outcome of HSC stimulation by exogenous cytokines would be highly useful. Although the extent to which individual HSC are biologically amenable to cytokine-determined alteration of their fates remains to be clarified,1,2 data from some in vivo studies has been interpreted as indicating that sustained HSC self-renewal, resulting in a significant net expansion of HSC numbers, may be constrained by the tissue environment.3-6 Moreover, the observation that cytokines such as interleukin (IL)-3 and tumor necrosis factor (TNF) have both been shown to exert HSC differentiation-inducing activities under certain conditions in vitro7,8 or that (murine) HSC self-renewal probabilities may be increased by infection with Friend murine leukemia virus9 or by overexpression of HOXB4,10 have renewed interest in the possibility of defining in vitro conditions that might allow the controlled manipulation of HSC self-renewal. However, neither the conditions under which these manipulations may be exploited nor their mechanisms of action at the cellular level have been defined. Even modest advances in this area could have an important medical impact, for example, in cord blood transplantation and gene therapy.

The introduction of quantitative and specific assays for hematopoietic cells capable of long-term multilineage repopulation in vivo11-16 has been key to assessing the magnitude of changes in HSC populations in vivo and in vitro. The use of these assays has established that a significant net expansion of HSC occurs during ontogeny17 and that this process can be reactivated in the adult during marrow regeneration.3,4 18 

Identification of in vitro conditions that will support a similar degree of HSC self-renewal activity has proven to be a major challenge, although recently, some success toward achieving this goal has occurred.6,12,15,19-24 Clues to why these groups have begun to succeed may lie in certain common features of their methodologies. These include the initiation of cultures with relatively low concentrations of cells that are enriched in their HSC content, frequent replacement of the medium, interactions of the HSC with particular stromal cell types, or the use of very high concentrations of selected cytokines. There are obviously certain intrinsic properties that can influence the magnitude of HSC amplification detected, including CXCR425 and VLA-426 expression and other parameters that may fluctuate during the cell cycle to specifically affect HSC engraftment in vivo,27,28 as well as factors that may limit the ultimate proliferative potential displayed by a given HSC without affecting its undifferentiated state (eg, telomere shortening29). However, an emerging theme from HSC expansion studies is that a net gain in HSC numbers requires the maintenance of some critical signaling ligand(s) above a threshold level. According to such a signaling-threshold model of stem cell differentiation control, when a relevant ligand-receptor interaction is kept above this threshold level, differentiation continues to be suppressed. When this threshold level is not maintained, the probability of a differentiation response being activated is increased. Thus, not only may the identity of a particular receptor-ligand interaction be important to the regulation of stem cell responses, the quantitative nature of this interaction may also have a significant influence on stem cell fate. In this review, we will examine some of the evidence that receptor activation thresholds, achieved through interaction with either soluble or surface-immobilized ligands, can regulate stem cell self-renewal versus differentiation responses.

Evidence from hematopoiesis

Several lines of evidence support the idea that quantitative changes in receptor/ligand signaling complex numbers may modulate HSC fate. Our recent comparison of the cytokine dose-response relationship for the amplification of hematopoietic progenitors (detected as colony-forming cells [CFC]) and HSC (detected as long-term culture-initiating cells [LTC-IC]) provided an important clue that these responses might involve pathways distinct from (or additional to) those responsible for blocking apoptosis and stimulating S-phase entry. The relevant key finding in these studies was the observation that to maximize LTC-IC expansion, it is necessary not only to stimulate cells with particular cytokines,30 but also to present these cytokines at very high concentrations—in fact more than 10-fold higher than the concentrations of the same cytokines that are sufficient to maximize the expansion of CFC numbers in the same cultures.8 Experiments were then performed with single CD34+CD38 cells to determine whether the reduced LTC-IC production at low cytokine concentrations was simply due to a failure of these conditions to stimulate a subset of CD34+CD38 cells with high LTC-IC generating potential. The results did not support such a model. We found no difference in the number of cells initially stimulated to divide (clone frequency) nor in the total number of progeny they generated (clone size distribution) under the 2 cytokine conditions, despite the expected difference in the number of progeny with LTC-IC activity (Figure 1). Similarly Bennaceur-Griscelli et al31 observed an enhanced preservation of LTC-IC in the presence of a stromal cell line, which was also independent of cellular survival and proliferation.

Fig. 1.

Clone formation and progenitor expansion from single cell cultures of CD34+CD38 adult human bone marrow cells.

CD34+CD38 cells were isolated and cultured as single cells in serum-free medium in the presence of 300 ng/mL stem cell factor, Flt-3 ligand, and 60 ng/mL IL-3 (High) or 30 ng/mL stem cell factor, Flt-3 ligand, and 6 ng/mL IL-3 (Low) for 10 days before analysis. Analysis consisted of determining the number of clones produced under each condition and then performing LTC-IC and CFC assays on a pool of each set of clones generated under the same condition. These studies showed that although the same number of clones and CFC were generated in the High versus the Low cytokine concentrations, the net generation of LTC-IC was dramatically affected by changes in cytokine concentration. Taken together these results suggested that self-renewal versus differentiation, not self-renewal versus survival, was being modulated. Results are from reference 8.

Fig. 1.

Clone formation and progenitor expansion from single cell cultures of CD34+CD38 adult human bone marrow cells.

CD34+CD38 cells were isolated and cultured as single cells in serum-free medium in the presence of 300 ng/mL stem cell factor, Flt-3 ligand, and 60 ng/mL IL-3 (High) or 30 ng/mL stem cell factor, Flt-3 ligand, and 6 ng/mL IL-3 (Low) for 10 days before analysis. Analysis consisted of determining the number of clones produced under each condition and then performing LTC-IC and CFC assays on a pool of each set of clones generated under the same condition. These studies showed that although the same number of clones and CFC were generated in the High versus the Low cytokine concentrations, the net generation of LTC-IC was dramatically affected by changes in cytokine concentration. Taken together these results suggested that self-renewal versus differentiation, not self-renewal versus survival, was being modulated. Results are from reference 8.

Close modal

More recently, Ramsfjell et al32 have confirmed and extended our studies by showing that the cytokine concentrations required to amplify hematopoietic cells with extended LTC-IC (ELTC-IC) are significantly higher than the cytokine concentrations required to amplify LTC-IC that produce CFC after shorter periods of time. Using cell division tracking studies, they further showed that the observed cytokine concentration effect was independent of the rate or extent of cell proliferation.

These results are, of course, not the only ones to show that the differentiation of primitive hematopoietic cells can be affected by the types or levels of cytokines used to stimulate them. Metcalf et al first showed almost 20 years ago that the proliferative activity and lineage commitment of bipotent granulocyte-macrophage progenitors could be shifted according to the concentration and order of granulocyte-macrophage colony-stimulating factor (GM-CSF) or macrophage colony-stimulating factor (M-CSF) to which the cells were initially exposed.33,34 More recently, evidence of a differentiation-inducing effect of IL-5 or thrombopoietin, in combination with steel factor, on murine progenitor cells was presented.35 Extended “self-renewal” of erythroid progenitors stimulated by insulin-like growth factor rather than insulin36 and their accelerated differentiation by exposure to transforming growth factor (TGF)-β37 have also been reported. Finally, IL-3 concentration-dependent control of proliferation and differentiation of murine FDCP-mix cells38,39 and a concentration-dependent ability of IL-3 and IL-1 to suppress the self-renewal of murine stem cells40 have been observed.

A further message from a large number of studies is the ability of particular feeder cell types to improve stem cell maintenance in vitro.23,31,41,42 Although these observations may indicate the production by these feeders of novel cytokines or nontoxic inhibitors of differentiation, a capacity to stimulate more prolonged signaling by sustained receptor activation may also be important.43 In studies with (predominantly) membrane-bound steel factor (SF), prevention of internalization prolonged tyrosine kinase activation and the half-life of the SF receptor on the surface of the responsive cells.43,44Transmembrane SF is a more potent stimulant of primordial germ cell survival in vitro than soluble SF and, in vivo, the SLdmutation (which causes only a soluble form of SF to be produced45) results in significant hematopoietic and developmental abnormalities including severe anemia, sterility, and progenitor cell defects.46 In fact, the positive effects of cell surface–bound ligand presentation may derive from both the high effective local concentration achieved47 and the inhibition of receptor internalization that occurs after soluble ligand-receptor interactions.48 

It is interesting to note that thresholds in receptor expression/activation have also been shown to be important in T- and B-cell development/lineage commitment.49-51 In fact, similar to our studies with HSC, it is not the presence or absence of a particular receptor that acts as a developmental switch, but the relative levels of surface expression that appear to govern developmental potential.51 Particularly interesting in this regard are data that show a clear difference in the sensitivity of responses of mature and immature B-cells.50 In these studies, low activation signals to immature B cells (induced by low antigen concentrations) resulted in clonal elimination (differentiation), whereas higher signal thresholds were required for clonal expansion. In the T-cell system, Smith52 has shown that the cell cycle progression of T cells can be predicted based on changes in IL-2 concentration, IL-2 receptor density, and the duration of receptor activation. Particularly noteworthy is the finding that gaussian distributions in cycle progression times closely correlate with parallel differences in IL-2 receptor expression, even within otherwise identical clonal T-cell populations. This suggests that the rate-limiting step in the IL-2–stimulated expansion of T-cell populations is the interaction of IL-2 with its receptor. From studies of the responses of separated T-cell subpopulations isolated on the basis of their individual IL-2 receptor densities, evidence has been obtained to indicate that some finite number of ligand/receptor interactions must occur before the cell replicates its DNA.53 Under the same conditions, this threshold may be reached earlier in cells expressing a high number of receptors than in cells expressing a low number of receptors. Moreover, a recent study has shown that the potency of IL-2 for stimulation of T-cell proliferation is enhanced by a ligand mutation that reduces its endocytic degradation54 (thereby resulting in prolonged receptor stimulation).

Evidence from nonhematopoietic systems

The role of inductive membrane-associated or soluble concentration gradients in activating distinct genetic programs during embryonic development and tissue specification is also well documented (for recent reviews see references 55 and 56). Cell secreted factors—morphogens—form concentration gradients over distances of more than 300 μm and thereby elicit positional information that dictates tissue patterning. Current evidence indicates that these gradients are relatively stable and may involve the diffusion of soluble factors across many cells, as well as juxtacrine57and transcytotic58 cell relay. Examples of molecules that form gradients resulting in spatially distinct tissue specification during vertebrate development include members of the TGF-β family (ie, activin, TGF-β, bone morphogenic proteins [BMPs]). Mesoderm development in Xenopus is induced by treating presumptive ectoderm with activin. Low concentrations result in the induction of hematopoietic tissue, whereas very high concentrations induce the development of notochord.59 The ability of cells to respond to many factors, or factor complexes with overlapping activities, as well as the existence of complex intersecting concentration gradients of these factors suggests that relative concentrations of factors, not just their absolute magnitudes, are important. The observation that dorsal-ventral patterning inDrosophila is positionally mediated by a morphogen called short gastrulation (Sog) and its interaction with decapentaplegic (Dpp), a secreted protein that belongs to the family of BMPs, exemplifies the types of elaborate mechanisms for the control of signaling thresholds that exist.60 Similarly, lineage determination during neural crest stem cell differentiation is instructively influenced by the timing and relative dosage of growth factor encountered (reviewed in Morrison et al61).

Recently, much attention has been directed toward the possible roles of fibroblast growth factor (FGF) signaling in early mammalian development. For example, signaling by the FGF receptor is required for the normal development of multiple organs during embryogenesis62 and may be spatially and directionally modulated by secretion and presentation of FGF by the extraembryonic trophectoderm.63 Further complexity is generated by the presence of membrane-bound and secreted receptor isoforms and by the interaction of FGF ligands with heparin sulfate proteoglycans on the cell surface and extracellular matrix.64 The availability of multiple, highly developed ways of controlling the local concentration of FGF in fetal tissues points to the importance of a threshold-based mechanism of FGF control of developmental processes.

Perhaps the most experimentally accessible model for the threshold-dependent regulation of stem cell self-renewal and differentiation is provided from in vitro studies of embryonic stem (ES) cell responses. A well-established feature of ES cells is their ability to be maintained in culture in an undifferentiated state in the presence of high concentrations of cytokines from the IL-6 family,65 the biologic action of which is mediated by multiple subunit cell surface receptors that share the gp130 protein. In fact, the concentration of the IL-6 type of cytokines required to prevent ES cell differentiation is dependent on the identity of the ligand.66 Like the HSC regulation by different concentrations of soluble cytokines mentioned above, analysis of ES cell responses to leukemia inhibitory factor (LIF) indicates that changes in extracellular ligand concentration directly influence the probability of differentiation independent of effects on the rate of ES cell proliferation.67 Our more recent studies using the J1 and D3 ES cell lines have extended these results by showing that the potency of the mitogenic stimulus required to maintain ES cell pluripotency may be related to the numbers of LIF receptors expressed by each ES cell line.81 In fact, in ES cells, as in PC12 neuronal cells, the level of receptor occupancy appears to determine the self-renewal versus differentiation decision.67 

What might be the mechanisms by which high levels of cytokines selectively promote HSC self-renewal? We know that the continual stimulation of responsive cells by cytokines is a dynamic process with significant changes occurring over many different time scales. Formation of ligand-receptor complexes results in the recruitment and activation of specific intracellular molecules that then initiate different signaling pathways. At any specific point in time and spatial position, the number of ligand-receptor complexes per cell depends on 2 variables—the number of unoccupied receptors available and the ligand concentration—and one parameter—the ligand-receptor binding affinity. However, the 2 variables can change as a function of time or spatial position (or both), so that the number of ligand-receptor complexes can consequently change. It is also conceivable that accessory molecular factors, either inside (eg, signaling intermediates) or outside (eg, receptor agonists/antagonists) the cell can influence the parametric value of the ligand/receptor binding affinity. Thus, mechanisms that govern cell receptor number and ligand concentration can be predicted to correspondingly govern whether or not the resulting complex-activated signal(s) remain(s) above a threshold level.

If binding affinity is sufficiently great that the ligand/receptor complex remains stable during the usually relatively brief time required to internalize the receptor (about 10 minutes),68the ligand may be rapidly depleted from the extracellular milieu by cellular endocytic degradation of receptor-ligand complexes.48,54,69 This internalization and degradation of receptors can also result in their down-regulation.48,70Simultaneously, on the time scale of a cell division cycle, newly synthesized or recycled receptors (or both) can typically be re-expressed on the cell surface.71,72 Sustained signal propagation, itself, can result in protein-mediated desensitization of the complex to further signaling73 or perhaps the depletion of intracellular signaling intermediates. Thus, some metric characterizing the number of ligand-receptor complexes per cell is likely to determine the types and magnitude of the signals activated. (Indeed, it might be important to further characterize the homogeneity of ligand-receptor complexes on the cell surface and between the cell surface and intracellular compartments, because signaling pathway fluxes may also be altered by differences in these distributions.72) Hence, by careful quantitation of changes in receptor levels to improve understanding of the parameters that influence these changes, it may be possible to develop rational strategies to enhance HSC self-renewal divisions.

It is important to note that the kinetics of ligand-stimulated receptor-mediated action depend exquisitely on the molecular properties of the receptor-ligand pair. Our investigations into the kinetics of epidermal growth factor (EGF) binding to its receptor are consistent with the concept that information essential for regulating cellular changes can be found in both the magnitude and the persistence of the cytokine signal (not simply the presence of the signal per se).74 When the response of wild-type cells was compared with cells expressing a carboxy-terminal truncated EGF receptor mutant that is deficient in ligand-induced internalization,75proliferation rather than death of the 2 cell types was similar only when EGF depletion was minimized by medium replenishment,76 or when a mutant EGF with a significantly reduced binding affinity was used.71,77 These results suggest that a dynamic integration of the kinetics of receptor binding, internalization, and degradation may be important to relate cellular proliferation/death decisions to the number of ligand-receptor complexes activated. Similar findings have emerged more recently for control of T-lymphocyte proliferation by IL-2.54,69Moreover, results showing than a similar model is applicable to the regulation of hepatocyte differentiation by IL-6 and soluble IL-6 receptor (sIL-6R) (and “hyper-IL-6”—a fusion protein of Il-6 and sIL-6R78) have been reported.70 Taken together, these findings support the application of these concepts to other systems where proliferation may be associated with a change in cellular phenotype.

The model we are proposing (summarized diagrammatically in Figure2) envisages that the fraction of cells undergoing a self-renewal division depends on the numbers of signaling ligand-receptor complexes as compared to a given threshold level. If a cell is expressing sufficiently high numbers of the relevant receptors and is exposed to sufficiently high concentrations of the cognate ligands, so that the number of ligand-receptor signaling complexes is above a certain threshold, the probability that the cell will then undergo a self-renewal division will be high. Conversely, if a cell expresses too few receptors, or if its receptors have been sufficiently down-regulated, or if the cognate ligand concentrations are sufficiently depleted, the number of ligand/receptor signaling complexes is likely to fall below this threshold, with the consequence that the proportion of cells in the population that then undergo a self-renewal division will be significantly reduced. In either situation, the threshold comparison must be to some time-integration of the ligand-receptor complex numbers and resulting signal transduction. One especially interesting prediction from this model, with great potential for technologic applications, is that presentation of the ligand in a mode that minimizes ligand depletion or receptor down-regulation can potentially enhance the likelihood that suprathreshold complex levels will be maintained, hence the probability of self-renewal cell divisions occurring will be maximized. This prediction has, as implied previously, been borne out in the cases of EGF and IL-2 in the regulation of proliferation responses of fibroblasts and T lymphocytes, respectively.54,69 71 

Fig. 2.

A ligand-receptor signaling threshold (LIST) model of stem cell differentiation control.

Examples of different mechanisms by which proliferating cells can move from a net loss in the numbers of undifferentiated cells (scenario A), to a net gain of undifferentiated cells (scenario B), as well as the reverse of this process, are listed. See text for further discussion.

Fig. 2.

A ligand-receptor signaling threshold (LIST) model of stem cell differentiation control.

Examples of different mechanisms by which proliferating cells can move from a net loss in the numbers of undifferentiated cells (scenario A), to a net gain of undifferentiated cells (scenario B), as well as the reverse of this process, are listed. See text for further discussion.

Close modal

Measurements of low (but present) numbers of cytokine receptors on hematopoietic progenitors79 further substantiates this model by allowing spatially or temporally controlled changes in ligand densities to result in greater relative changes in the fraction of occupied receptors.80 (The temporal variance in the number of receptors bound at a constant ligand concentration is inversely proportional to receptor number, ie, if the cell has only one receptor, it fluctuates between the bound and unbound state at a binding constant-dependent rate.68) This model may also go a long way to explaining the heterogeneity of responses of seemingly identical cell populations to the same culture conditions. For example, given the order of magnitude differences in gp130 receptor numbers on ES cells, it is likely that, even at the highest LIF concentration, a proportion of cells may not be able to form sufficient numbers of ligand-receptor complexes to elicit a self-renewal division. This hypothesis is consistent with observations by our group,81 as well as others67 in various ES cell lines.

The existence of overlapping domains in many cytokine receptors may also be consistent with this model. Here we view self-renewal versus differentiation as a simple yes/no response, despite the fact that the events leading up to this decision must be at least as complex as the numbers of cytokines to which the cell may be sensitive. Because the signaling threshold is determined by receptor expression or availability, the effective ligand concentration, and the particular binding properties of the ligand/receptor pair, multiple scenarios may result in an intensity of signaling required to promote a “self-renewal” cell division. An experimental example of this can be found once again in the ES cell model, where the concentration of LIF, oncostatin M, and ciliary neurotrophic factor required to prevent differentiation differ significantly, even though these cytokines use the same gp130 transmembrane molecule for signaling.66Because each cytokine in this family has its own binding properties, but uses a limited number of common receptor subunits, the balance between competition for these different receptor subunits and ligand concentration may provide a mechanism for the differential control of cell responses to microenvironmental changes. Results showing that this family of cytokines may be organized as exchangeable modules,82 and the hypothesis that even for a particular cytokine, concentration-dependent changes in receptor complex stochiometry83 (each with their own signaling capacity) may exist, implicates additional levels of control that may influence how thresholds are (or are not) reached.

Of course, this model cannot be the whole story. First of all, the fact that very high concentrations of cytokines are required to differentially stimulate cells with low numbers of receptors suggests that the formation of active ligand-receptor complexes may be limited by the diffusion of low affinity partners in the plasma membrane.80 Other factors, such as receptor clustering or asymmetrical localization of other critical components are also likely to be important in allowing cells to respond to changes in the concentrations of protein signals over several orders of magnitude.84 

Although many of the previously discussed studies show that multipotential cells have the capacity to differentially respond to a wide range of concentrations of soluble ligands, multiple mechanisms, including autocrine,85-87 juxtacrine47,88 and exocrine89 stimulation, may be responsible for achieving the same level of control in vivo (Figure3). In fact, recent studies of autocrine cell signaling support the role of this mechanism in the robust control of ligand concentrations in the cellular microenvironment.90 As suggested earlier for SF, high levels of receptor activation can be obtained when responsive cells react with ligands that are expressed as transmembrane elements on the surface of other cells, or attached to extracellular matrix components.47 The prevalence transmembrane growth factors on primitive hematopoietic cells that can be converted to soluble factors by proteolytic processing or membrane shedding, without losing their biologic activity, provides yet another mechanism for the local control of cellular stimulation.91 Taken together, this suggests a model whereby transmembrane, soluble and extracellular matrix-bound cytokines provide a dynamically variable array of stimuli that can be stored in the cellular microenvironment.92Understanding the response patterns of cells to dynamic changes in such arrays could be key to developing an ability to predict the kinetics of cell behavior in different culture systems.

Fig. 3.

Examples of mechanisms that cells can use for the in vivo for the control of effective ligand concentrations and receptor expression (and thus the level of receptor-ligand complex activation).

(1) Preventing or diminishing ligand/receptor complex internalization through interactions between extracellular matrix (shown) or cell-surface bound ligands; (2) autocrine ligand secretion; (3) interactions with proteins secreted by other cells (either locally or systemically); (4) ligand interactions with agonistic or antagonistic soluble receptors (shown) or nonreceptor cytokine binding proteins (eg, uromodulin); (5) receptor internalization/synthesis; and (6) proteolytic cleavage of surface-bound receptors (shown) and/or ligands. Each of these mechanisms may determine whether a particular (threshold) level of receptor ligand activation is achieved. See text for further discussion.

Fig. 3.

Examples of mechanisms that cells can use for the in vivo for the control of effective ligand concentrations and receptor expression (and thus the level of receptor-ligand complex activation).

(1) Preventing or diminishing ligand/receptor complex internalization through interactions between extracellular matrix (shown) or cell-surface bound ligands; (2) autocrine ligand secretion; (3) interactions with proteins secreted by other cells (either locally or systemically); (4) ligand interactions with agonistic or antagonistic soluble receptors (shown) or nonreceptor cytokine binding proteins (eg, uromodulin); (5) receptor internalization/synthesis; and (6) proteolytic cleavage of surface-bound receptors (shown) and/or ligands. Each of these mechanisms may determine whether a particular (threshold) level of receptor ligand activation is achieved. See text for further discussion.

Close modal

The fact that serum levels of Flt3L are disregulated during leukemogenesis and transplantation,93,94 along with the documented ability of high concentrations of this cytokine to promote stem cell self-renewal,8 provides further evidence that changes in exogenous levels of particular cytokines may be important in regulating HSC differentiation in vivo. Similarly, the physiologic relevance of changes in the relative concentrations of other cytokines in regulating hematopoietic progenitors in vivo can be inferred from the altered serum cytokine levels that correlate with conditions of HSC recovery. For example, 2- to 3-fold changes in serum LIF and IL-3 concentrations in the autologous transplantation setting have been associated with an induction of HSC cycling and differentiation caused by myeloablation.95 Conversely, increased serum SF and Flt3L concentrations correlate with increased numbers of hematopoietic progenitors in some patients with aplastic anemia,89,93 and administration of these cytokines has been reported to have a therapeutic effect in this disease.96 It is important to note that the changes in progenitor numbers (both relative and absolute) in these and other studies are due to changes in the serum concentrations (not their presence or absence) of cytokines relative to untreated controls.

The differential expression of soluble and surface bound isoforms of many cytokines and their receptors is another way by which stimulatory levels of critical factors may be controlled. Indeed, the modulatory effects of cytokines that have been shown to be important in the regulation of embryonic and HSC responses, including FGF,97 LIF,98 SF,43 and Flt3L,99 can be regulated in this manner. In some cases at least, such changes are found to influence the ability of cytokines to bind to membrane receptors and subsequently generate a response.100 Although many examples of this regulation exist, the fact that soluble receptors generally retain their ligand binding ability and can act as either competitive inhibitors (eg, IL-1, IL-2, G-CSF101) or as positive effectors (sIL-6R102 103), gives an insight into the complex processes that have evolved to regulate ligand-stimulated thresholds.

Although evidence strongly suggests that threshold levels of receptor activation induced by soluble and bound factors can modulate the in vitro and in vivo responses of unspecialized cells, what has not been clarified are the downstream mechanisms by which such cells perceive and differentially respond to different levels of receptor activation. The idea that certain intracellular signaling thresholds stimulated by exogenous cytokines are important to cell fate decisions is not new.74 Receptors with intrinsic or associated tyrosine kinase activity are known to be capable of alternatively eliciting proliferative or differentiation responses in factor-dependent cell lines104-106 and it is likely that levels of signaling intermediates represent key determinants in these decisions. For example, both the duration and magnitude of extracellular signal-regulated kinase (ERK) activation by nerve growth factor (NGF) and EGF in the PC12 neuronal cell line influence whether these cells will proliferate or differentiate.107 The fact that a given cytokine can elicit different outcomes in the context of different expression levels of the corresponding receptor supports the view that a quantitative metric for signaling (eg, ERK activation) helps govern the biologic outcome in this system.108 

Recent studies of the regulation of ES cell self-renewal and differentiation suggest this system holds much promise for further analysis of this process. A critical step in connecting receptor occupancy to the genetic programs involved in ES differentiation is signaling though the JAK/STAT (janus kinase/signal transducer and activator of transcription) pathway. Evidence that intracellular STAT3 activation is involved in LIF-mediated changes in ES cell self-renewal is provided by the observation that a threshold level of STAT3 activation is essential for this response.67 Dimerization of gp130 by LIF induces both the Ras-mitogen activated protein kinase (MAPK) and JAK/STAT pathways in ES cells.109 The results of Raz et al67 suggest that it is the level of activated STAT3 that is critical to maintaining a block of ES cell differentiation, MAPK activity being predominantly associated with mitogenesis.

Importantly, this type of signaling regulation also has an in vivo parallel. In the preimplantation embryo, asymmetrical localization of STAT3 correlates with LIF concentration gradients during the morula stage of development.110 These concentration gradients may be achieved by incorporation of locally produced LIF into the surrounding extracellular matrix100 and may allow temporal and spatial control of differentiation decisions during this early stage of development. A prevalence of gp130-mediated responses in other stem cell systems, including HSC47,48,102,111-113 along with the documented importance of the JAK/STAT signaling pathway in hematopoiesis114 suggest that regulation of stem cell differentiation decisions by this family of cytokines may be widely conserved. Genetic evidence of common mechanisms regulating mammalian embryonic development, tissue patterning, and adult HSC differentiation115 provides further support for the generality of a model in which the numbers of effective ligand/receptor interactions control differentiation decisions.

Several fundamental questions must be answered before it will be feasible to usefully predict and control HSC responses to exogenous cytokines on other than empirical grounds. In particular, a better understanding of how specific cytokines may alter the fate of mitogenically activated HSC is needed. This is likely to require knowledge of both the dynamics of changes in stem cellpopulations occurring over prolonged periods, as well as the cellular fate outcomes of individual stem cell divisions.

These issues will be key to the design of bioreactors in which cytokine-mediated expansion of HSC populations would be achieved. It has been proposed that the successful use of cytokines in bioprocessing applications will require the control of 2 attenuation mechanisms, cytokine depletion and receptor down-regulation,71,116,117Measurements of cytokine depletion rates by hematopoietic cells48,17,119 underscore the importance of monitoring and appropriately regulating the concentrations of cytokines considered necessary for optimizing the growth of HSC in culture. Strict monitoring of cytokine concentrations is likely to be most important where a decrease in the cytokine concentration is known to affect the desired cellular response, or if the rate of cytokine depletion is high. This may be particularly important in mixed cell systems typical of hematopoietic expansion cultures, where cell type–specific rates of cytokine depletion (and secretion) have been demonstrated.118 

Additional studies are required to determine if modulation of the strength of receptor-induced signaling, possibly caused by differences in the timing, amount, or duration of receptor stimulation, can be linked to the activation of distinct programs of gene activity. A critical aspect of this analysis will be to measure temporal changes in the nuclear and cytoplasmic concentrations of intracellular intermediates such as the phosphorylated STAT proteins. Such information would not only facilitate the development of more controlled HSC expansion processes, it will undoubtedly also offer new insights into the fascinating biology of HCS self-renewal mechanisms.

Supported by a National Science Foundation Engineering Research Center (ERC) grant to the Biotechnology Process Engineering Center at the Massachusetts Institute of Technology and the National Cancer Institute of Canada (NCIC) with funds from the Terry Fox Run and P01HL 55435 from the National Institutes of Health (USA). P.W.Z. held a Natural Sciences and Engineering Research Council of Canada postdoctoral fellowship; C.J.E. is a Terry Fox Cancer Research Scientist of the NCIC.

The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked “advertisement” in accordance with 18 U.S.C. section 1734.

1
Metcalf
D
Lineage commitment and maturation in hematopoietic cells: the case for extrinsic regulation.
Blood.
92
1998
345
2
Enver
T
Heyworth
CM
Dexter
TM
Do stem cells play dice?
Blood.
92
1998
348
3
Iscove
NN
Nawa
K
Hematopoietic stem cells expand during serial transplantation in vivo without apparent exhaustion.
Curr Biol.
7
1997
805
4
Pawliuk
R
Eaves
C
Humphries
RK
Evidence of both ontogeny and transplant dose-regulated expansion of hematopoietic stem cells in vivo.
Blood.
88
1996
2852
5
Cashman
JD
Eaves
CJ
Human growth factor-enhanced regeneration of transplantable human hematopoietic stem cells in nonobese diabetic/severe combined immunodeficient mice.
Blood.
93
1999
481
6
Bhatia
M
Bonnet
D
Kapp
U
Wang
JC
Murdoch
B
Dick
JE
Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture.
J Exp Med.
186
1997
619
7
Maguer-Satta V, Reid D, Eaves CJ. Evidence that ceramide mediates the ability of TNF to modulate primitive hematopoietic cell fates. Blood. In press.
8
Zandstra
PW
Conneally
E
Petzer
AL
Piret
JM
Eaves
CJ
Cytokine manipulation of primitive human hematopoietic cell self-renewal.
Proc Natl Acad Sci U S A.
94
1997
4698
9
Eckner
RJ
Hettrick
KL
Greenberger
JS
Bennett
M
Extended self-renewal capacity of pluripotent hemopoietic stem cells: association with persistent Friend spleen focus-forming virus.
Cell.
31
1982
731
10
Sauvageau
G
Thorsteinsdottir
U
Eaves
CJ
et al
Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo.
Genes Dev.
9
1995
1753
11
Holyoake
TL
Nicolini
FE
Eaves
CJ
Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow.
Exp Hematol.
27
1999
1418
12
Conneally
E
Cashman
J
Petzer
A
Eaves
C
Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice.
Proc Natl Acad Sci U S A.
94
1997
9836
13
Trevisan
M
Yan
XQ
Iscove
NN
Cycle initiation and colony formation in culture by murine marrow cells with long-term reconstituting potential in vivo.
Blood.
88
1996
4149
14
Harrison
DE
Jordan
CT
Zhong
RK
Astle
CM
Primitive hemopoietic stem cells: direct assay of most productive populations by competitive repopulation with simple binomial, correlation and covariance calculations.
Exp Hematol.
21
1993
206
15
Miller
CL
Eaves
CJ
Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability.
Proc Natl Acad Sci U S A.
94
1997
13648
16
Szilvassy
SJ
Humphries
RK
Lansdorp
PM
Eaves
AC
Eaves
CJ
Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy.
Proc Natl Acad Sci U S A.
87
1990
8736
17
Eaves
C
Miller
C
Conneally
E
et al
Introduction to stem cell biology in vitro: threshold to the future.
Ann N Y Acad Sci.
872
1999
1
18
Cashman
JD
Lapidot
T
Wang
JC
et al
Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice.
Blood.
89
1997
4307
19
Yagi
M
Ritchie
KA
Sitnicka
E
Storey
C
Roth
GJ
Bartelmez
S
Sustained ex vivo expansion of hematopoietic stem cells mediated by thrombopoietin.
Proc Natl Acad Sci U S A.
96
1999
8126
20
Piacibello
W
Sanavio
F
Severino
A
et al
Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells.
Blood.
93
1999
3736
21
van Hennik
PB
Verstegen
MM
Bierhuizen
MF
et al
Highly efficient transduction of the green fluorescent protein gene in human umbilical cord blood stem cells capable of cobblestone formation in long-term cultures and multilineage engraftment of immunodeficient mice.
Blood.
92
1998
4013
22
Breems
DA
Blokland
EA
Siebel
KE
Mayen
AE
Engels
LJ
Ploemacher
RE
Stroma-contact prevents loss of hematopoietic stem cell quality during ex vivo expansion of CD34+ mobilized peripheral blood stem cells.
Blood.
91
1998
111
23
Brandt
JE
Galy
AH
Luens
KM
et al
Bone marrow repopulation by human marrow stem cells after long-term expansion culture on a porcine endothelial cell line.
Exp Hematol.
26
1998
950
24
Kollet
O
Aviram
R
Chebath
J
et al
The soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro maintenance and proliferation of human CD34(+)CD38(−/low) cells capable of repopulating severe combined immunodeficiency mice.
Blood.
94
1999
923
25
Peled
A
Petit
I
Kollet
O
et al
Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4.
Science.
283
1999
845
26
Papayannopoulou
T
Nakamoto
B
Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin.
Proc Natl Acad Sci U S A.
90
1993
9374
27
Habibian
HK
Peters
SO
Hsieh
CC
et al
The fluctuating phenotype of the lymphohematopoietic stem cell with cell cycle transit.
J Exp Med.
188
1998
393
28
Gothot
A
van der Loo
JC
Clapp
DW
Srour
EF
Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice.
Blood.
92
1998
2641
29
Rufer
N
Brummendorf
TH
Kolvraa
S
et al
Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood.
J Exp Med.
190
1999
157
30
Petzer
AL
Zandstra
PW
Piret
JM
Eaves
CJ
Differential cytokine effects on primitive (CD34+CD38−) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin.
J Exp Med.
183
1996
2551
31
Bennaceur-Griscelli
A
Tourino
C
Izac
B
Vainchenker
W
Coulombel
L
Murine stromal cells counteract the loss of long-term culture- initiating cell potential induced by cytokines in CD34(+)CD38(low/neg) human bone marrow cells.
Blood.
94
1999
529
32
Ramsfjell
V
Bryder
D
Bjorgvinsdottir
H
et al
Distinct requirements for optimal growth and in vitro expansion of human CD34(+)CD38(−) bone marrow long-term culture-initiating cells (LTC-IC), extended LTC-IC, and murine in vivo long-term reconstituting stem cells.
Blood.
94
1999
4093
33
Metcalf
D
Clonal analysis of proliferation and differentiation of paired daughter cells: action of granulocyte-macrophage colony-stimulating factor on granulocyte-macrophage precursors.
Proc Natl Acad Sci U S A.
77
1980
5327
34
Metcalf
D
Burgess
AW
Clonal analysis of progenitor cell commitment of granulocyte or macrophage production.
J Cell Physiol.
111
1982
275
35
Metcalf
D
Lineage commitment in the progeny of murine hematopoietic preprogenitor cells: influence of thrombopoietin and interleukin 5.
Proc Natl Acad Sci U S A.
95
1998
6408
36
Panzenbock
B
Bartunek
P
Mapara
MY
Zenke
M
Growth and differentiation of human stem cell factor/erythropoietin-dependent erythroid progenitor cells in vitro.
Blood.
92
1998
3658
37
Krystal
G
Lam
V
Dragowska
W
et al
Transforming growth factor beta 1 is an inducer of erythroid differentiation.
J Exp Med.
180
1994
851
38
Heyworth
CM
Dexter
TM
Kan
O
Whetton
AD
The role of hemopoietic growth factors in self-renewal and differentiation of IL-3-dependent multipotential stem cells.
Growth Factors.
2
1990
197
39
Dexter
TM
Heyworth
CM
Spooncer
E
Ponting
IL
The role of growth factors in self-renewal and differentiation of haemopoietic stem cells.
Philos Trans R Soc Lond B Biol Sci.
327
1990
85
40
Yonemura
Y
Ku
H
Hirayama
F
Souza
LM
Ogawa
M
Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells.
Proc Natl Acad Sci U S A.
93
1996
4040
41
Koller
MR
Manchel
I
Palsson
BO
Importance of parenchymal:stromal cell ratio for the ex vivo reconstitution of human hematopoiesis.
Stem Cells.
15
1997
305
42
Toksoz
D
Zsebo
KM
Smith
KA
et al
Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor.
Proc Natl Acad Sci U S A.
89
1992
7350
43
Miyazawa
K
Williams
DA
Gotoh
A
Nishimaki
J
Broxmeyer
HE
Toyama
K
Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form.
Blood.
85
1995
641
44
Avraham
H
Scadden
DT
Chi
S
Broudy
VC
Zsebo
KM
Groopman
JE
Interaction of human bone marrow fibroblasts with megakaryocytes: role of the c-kit ligand.
Blood.
80
1992
1679
45
Flanagan
JG
Chan
DC
Leder
P
Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant.
Cell.
64
1991
1025
46
Witte
ON
Steel locus defines new multipotent growth factor.
Cell.
63
1990
5
47
Francis
K
Palsson
BO
Effective intercellular communication distances are determined by the relative time constants for cyto/chemokine secretion and diffusion.
Proc Natl Acad Sci U S A.
94
1997
12258
48
Zandstra
PW
Jervis
E
Haynes
CA
Kilburn
DG
Eaves
CJ
Piret
JM
Concentration-dependent internalization of a cytokine/cytokine receptor complex in human hematopoietic cells.
Biotechnol Bioeng.
63
1999
493
49
Chidgey
A
Boyd
R
Agonist peptide modulates T cell selection thresholds through qualitative and quantitative shifts in CD8 co-receptor expression.
Int Immunol.
9
1997
1527
50
Benschop
RJ
Melamed
D
Nemazee
D
Cambier
JC
Distinct signal thresholds for the unique antigen receptor-linked gene expression programs in mature and immature B cells.
J Exp Med.
190
1999
749
51
Bachmann
MF
Barner
M
Kopf
M
CD2 sets quantitative thresholds in T cell activation.
J Exp Med.
190
1999
1383
52
Smith
KA
Cell growth signal transduction is quantal.
Ann N Y Acad Sci.
766
1995
263
53
Cantrell
DA
Smith
KA
The interleukin-2 T-cell system: a new cell growth model.
Science.
224
1984
1312
54
Fallon
EM
Liparoto
SF
Lee
KJ
Ciardelli
TL
Lauffenburger
DA
Increased endosomal sorting of ligand to recycling enhanses potency of an interleukin-2 analog.
J Biol Chem.
275
2000
6790
55
Dale
L
Development: morphogen gradients and mesodermal patterning.
Curr Biol.
7
1997
R698
56
Wolpert
L
One hundred years of positional information.
Trends Genet.
12
1996
359
57
Reilly
KM
Melton
DA
Short-range signaling by candidate morphogens of the TGF beta family and evidence for a relay mechanism of induction.
Cell.
86
1996
743
58
Brandli
AW
Adamson
ED
Simons
K
Transcytosis of epidermal growth factor: the epidermal growth factor receptor mediates uptake but not transcytosis.
J Biol Chem.
266
1991
8560
59
Green
JB
New
HV
Smith
JC
Responses of embryonic Xenopus cells to activin and FGF are separated by multiple dose thresholds and correspond to distinct axes of the mesoderm.
Cell.
71
1992
731
60
Ashe
HL
Levine
M
Local inhibition and long-range enhancement of Dpp signal transduction by Sog.
Nature.
398
1999
427
61
Morrison
SJ
Shah
NM
Anderson
DJ
Regulatory mechanisms in stem cell biology.
Cell.
88
1997
287
62
Celli
G
LaRochelle
WJ
Mackem
S
Sharp
R
Merlino
G
Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning.
EMBO J.
17
1998
1642
63
Tanaka
S
Kunath
T
Hadjantonakis
AK
Nagy
A
Rossant
J
Promotion of trophoblast stem cell proliferation by FGF4.
Science.
282
1998
2072
64
Johnson
DE
Williams
LT
Structural and functional diversity in the FGF receptor multigene family.
Adv Cancer Res.
60
1993
1
65
Williams
RL
Hilton
DJ
Pease
S
et al
Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells.
Nature.
336
1988
684
66
Piquet-Pellorce
C
Grey
L
Mereau
A
Heath
JK
Are LIF and related cytokines functionally equivalent?
Exp Cell Res.
213
1994
340
67
Raz
R
Lee
CK
Cannizzaro
LA
d'Eustachio
P
Levy
DE
Essential role of STAT3 for embryonic stem cell pluripotency.
Proc Natl Acad Sci U S A.
96
1999
2846
68
Lauffenburger
DA
Linderman
JJ
Receptors: Models for Binding Trafficking and Signaling.
1993
Oxford University Press
New York
69
Lauffenburger
DA
Fallon
EM
Haugh
JM
Scratching the (cell) surface: cytokine engineering for improved ligand/receptor trafficking dynamics.
Chem Biol.
5
1998
R257
70
Peters
M
Blinn
G
Solem
F
Fischer
M
Meyer zum Buschenfelde
KH
Rose-John
S
In vivo and in vitro activities of the gp130-stimulating designer cytokine hyper-IL-6.
J Immunol.
161
1998
3575
71
Reddy
CC
Niyogi
SK
Wells
A
Wiley
HS
Lauffenburger
DA
Engineering epidermal growth factor for enhanced mitogenic potency.
Nat Biotechnol.
14
1996
1696
72
Haugh
JM
Schooler
K
Wells
A
Wiley
HS
Lauffenburger
DA
Effect of epidermal growth factor receptor internalization on regulation of the phospholipase C-gamma1 signaling pathway.
J Biol Chem.
274
1999
8958
73
Starr
R
Willson
TA
Viney
EM
et al
A family of cytokine-inducible inhibitors of signalling.
Nature.
387
1997
917
74
Marshall
CJ
Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.
Cell.
80
1995
179
75
Chen
WS
Lazar
CS
Lund
KA
et al
Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulation.
Cell.
59
1989
33
76
Reddy
CC
Wells
A
Lauffenburger
DA
Proliferative response of fibroblasts expressing internalization-deficient epidermal growth factor (EGF) receptors is altered via differential EGF depletion effect.
Biotechnol Prog.
10
1994
377
77
Tadaki
DK
Niyogi
SK
The functional importance of hydrophobicity of the tyrosine at position 13 of human epidermal growth factor in receptor binding.
J Biol Chem.
268
1993
10114
78
Fischer
M
Goldschmitt
J
Peschel
C
et al
I. A bioactive designer cytokine for human hematopoietic progenitor cell expansion.
Nat Biotechnol.
15
1997
142
79
McKinstry
WJ
Li
CL
Rasko
JE
Nicola
NA
Johnson
GR
Metcalf
D
Cytokine receptor expression on hematopoietic stem and progenitor cells.
Blood.
89
1997
65
80
Wiley
HS
Anomalous binding of epidermal growth factor to A431 cells is due to the effect of high receptor densities and a saturable endocytic system.
J Cell Biol.
107
1988
801
81
Zandstra PW, Le HV, Daley GQ, Griffith LG, and Lauffenburger DA. Leukemia inhibitory factor (LIF) concentration modulates embryonic stem cell self-renewal and differentiation independently of proliferation. Biotechnol Bioeng. In press.
82
Kallen
KJ
Grotzinger
J
Lelievre
E
et al
Receptor recognition sites of cytokines are organized as exchangeable modules: transfer of the leukemia inhibitory factor receptor-binding site from ciliary neurotrophic factor to interleukin-6.
J Biol Chem.
274
1999
11859
83
Grotzinger
J
Kernebeck
T
Kallen
KJ
Rose-John
S
IL-6 type cytokine receptor complexes: hexamer, tetramer or both?
Biol Chem.
380
1999
803
84
Bray
D
Levin
MD
Morton-Firth
CJ
Receptor clustering as a cellular mechanism to control sensitivity.
Nature.
393
1998
85
85
Sporn
MB
Roberts
AB
Autocrine secretion—10 years later.
Ann Intern Med.
117
1992
408
86
Lauffenburger
D
Cozens
C
Regulation of mammalian cell growth by autocrine growth factors: analysis of consequences for inoculum cell density effects.
Biotech Bioeng.
33
1989
1365
87
Lauffenburger
DA
Oehrtman
GT
Walker
L
Wiley
HS
Real-time quantitative measurement of autocrine ligand binding indicates that autocrine loops are spatially localized.
Proc Natl Acad Sci U S A.
95
1998
15368
88
Majumdar
MK
Feng
L
Medlock
E
Toksoz
D
Williams
DA
Identification and mutation of primary and secondary proteolytic cleavage sites in murine stem cell factor cDNA yields biologically active, cell-associated protein.
J Biol Chem.
269
1994
1237
89
Wodnar-Filipowicz
A
Lyman
SD
Gratwohl
A
Tichelli
A
Speck
B
Nissen
C
Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia.
Blood.
88
1996
4493
90
Oehrtman
GT
Wiley
HS
Lauffenburger
DA
Escape of autocrine ligands into extracellular medium: experimental test of theoretical model predictions.
Biotechnol Bioeng.
57
1998
571
91
Heaney
ML
Golde
DW
Soluble cytokine receptors.
Blood.
87
1996
847
92
Nathan
C
Sporn
M
Cytokines in context.
J Cell Biol.
113
1991
981
93
Wodnar-Filipowicz
A
Yancik
S
Moser
Y
et al
Levels of soluble stem cell factor in serum of patients with aplastic anemia.
Blood.
81
1993
3259
94
Zwierzina
H
Anderson
JE
Rollinger-Holzinger
I
Torok-Storb
B
Nuessler
V
Lyman
SD
Endogenous FLT-3 ligand serum levels are associated with disease stage in patients with myelodysplastic syndromes.
Leukemia.
13
1999
553
95
Testa
U
Martucci
R
Rutella
S
et al
Autologous stem cell transplantation: release of early and late acting growth factors relates with hematopoietic ablation and recovery.
Blood.
84
1994
3532
96
Kumar
M
Alter
BP
Hematopoietic growth factors for the treatment of aplastic anemia.
Curr Opin Hematol.
5
1998
226
97
LaRochelle
WJ
Sakaguchi
K
Atabey
N
et al
Heparan sulfate proteoglycan modulates keratinocyte growth factor signaling through interaction with both ligand and receptor.
Biochemistry.
38
1999
1765
98
Rathjen
PD
Nichols
J
Toth
S
Edwards
DR
Heath
JK
Smith
AG
Developmentally programmed induction of differentiation inhibiting activity and the control of stem cell populations.
Genes Dev.
4
1990
2308
99
Lyman
SD
James
L
Escobar
S
et al
Identification of soluble and membrane-bound isoforms of the murine flt3 ligand generated by alternative splicing of mRNAs.
Oncogene.
10
1995
149
100
Rathjen
PD
Toth
S
Willis
A
Heath
JK
Smith
AG
Differentiation inhibiting activity is produced in matrix-associated and diffusible forms that are generated by alternate promoter usage.
Cell.
62
1990
1105
101
Fernandez-Botran
R
Soluble cytokine receptors: basic immunology and clinical applications.
Crit Rev Clin Lab Sci.
36
1999
165
102
Peters
M
Muller
AM
Rose-John
S
Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis.
Blood.
92
1998
3495
103
Schobitz
B
Pezeshki
G
Pohl
T
et al
Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo.
FASEB J.
9
1995
659
104
Yoshida
K
Chambers
I
Nichols
J
et al
Maintenance of the pluripotential phenotype of embryonic stem cells through direct activation of gp130 signalling pathways.
Mech Dev.
45
1994
163
105
Schlessinger
J
Ullrich
A
Growth factor signaling by receptor tyrosine kinases.
Neuron.
9
1992
383
106
Heinrich
PC
Behrmann
I
Muller-Newen
G
Schaper
F
Graeve
L
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.
Biochem J.
334
1998
297
107
Traverse
S
Gomez
N
Paterson
H
Marshall
C
Cohen
P
Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells: comparison of the effects of nerve growth factor and epidermal growth factor.
Biochem J.
288
1992
351
108
Traverse
S
Seedorf
K
Paterson
H
Marshall
CJ
Cohen
P
Ullrich
A
EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor.
Curr Biol.
4
1994
694
109
Tsuzuki
M
Ezaki
K
Maruyama
F
et al
Proliferative effects of several hematopoietic growth factors on acute myelogenous leukemia cells and correlation with treatment outcome.
Leukemia.
11
1997
2125
110
Antczak
M
Van Blerkom
J
Oocyte influences on early development: the regulatory proteins leptin and STAT3 are polarized in mouse and human oocytes and differentially distributed within the cells of the preimplantation stage embryo.
Mol Hum Reprod.
3
1997
1067
111
Zandstra
PW
Conneally
E
Piret
JM
Eaves
CJ
Ontogeny-associated changes in the cytokine responses of primitive human haemopoietic cells.
Br J Haematol.
101
1998
770
112
Ogawa
M
Differentiation and proliferation of hematopoietic stem cells.
Blood.
81
1993
2844
113
Holyoake
TL
Freshney
MG
McNair
L
et al
Ex vivo expansion with stem cell factor and interleukin-11 augments both short-term recovery posttransplant and the ability to serially transplant marrow.
Blood.
87
1996
4589
114
Ward
AC
Touw
I
Yoshimura
A
The jak-stat pathway in normal and perturbed hematopoiesis.
Blood.
95
2000
19
115
Zon
LI
Developmental biology of hematopoiesis.
Blood.
86
1995
2876
116
Audet
J
Zandstra
PW
Eaves
CJ
Piret
JM
Advances in hematopoietic stem cell culture.
Curr Opin Biotechnol.
9
1998
146
117
Zandstra
PW
Eaves
CJ
Piret
JM
Environmental requirements of hematopoietic progenitor cells in ex vivo expansion systems.
Ex Vivo Cell Therapy.
Schindhelm
K
Nordon
R
1999
Academic Press
New York
118
Zandstra
PW
Petzer
A
Eaves
CJ
Piret
JM
Cellular determinants affecting the rate of cytokine depletion in cultures of human hematopoietic cells.
Biotechnol Bioeng.
54
1997
58
119
Koller
MR
Bradley
MS
Palsson
BO
Growth factor consumption and production in perfusion cultures of human bone marrow correlate with specific cell production.
Exp Hematol.
23
1995
1275

Author notes

Peter W. Zandstra, Institute of Biomaterials and Biomedical Engineering, Rm 407, Roseburgh Bldg, 4 Taddle Creek Rd, Toronto, Ontario M5S 3G9, Canada; e-mail.zandstra@ibme.utoronto.ca.

Sign in via your Institution